43 results
424B5
ABBV
Abbvie Inc
26 Feb 24
Prospectus supplement for primary offering
6:12am
and accompanying prospectus are appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
United
424B5
ABBV
Abbvie Inc
21 Feb 24
Prospectus supplement for primary offering
8:39am
prospectus are appropriate to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters.
United Kingdom
PX14A6G
ABBV
Abbvie Inc
4 May 23
Letter to shareholders
8:08am
is Difficult to Obtain
Obtaining comprehensive information on lobbying at the state level is described by one expert as “nearly impossible” given
8-K
EX-3.1
kp3fnoz
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
PX14A6G
s2uji3 5cckhzq0
15 Apr 21
Letter to shareholders
1:10pm
PX14A6G
bqk1e
7 Apr 20
Letter to shareholders
9:08am
8-K
EX-99.1
vp1th9hsyn8so
7 Nov 19
Other Events
9:17am
8-K
EX-99.2
fwxutnz2hn7jj vo
16 Sep 19
Index to Consolidated Financial Statements
6:08am
PX14A6G
luadapdzoxwwtuxjw
17 Apr 19
Letter to shareholders
1:46pm
424B3
fkp9p1e6v g42r4x
8 Jul 13
Prospectus supplement
12:00am